These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 18038689

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis.
    Hofbauer GF, Marcollo-Pini A, Corsenca A, Kistler AD, French LE, Wüthrich RP, Serra AL.
    Br J Dermatol; 2008 Aug; 159(2):473-5. PubMed ID: 18547304
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Unilateral Facial Angiofibromas.
    Basu D, Kumar P, Das A.
    Skinmed; 2019 Aug; 17(1):52-53. PubMed ID: 30888949
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Multiple facial angiofibromas treated with high-frequency equipment.
    Gomes AA, Gomes YV, Lima FB, Pessoa SG.
    An Bras Dermatol; 2011 Aug; 86(4 Suppl 1):S186-9. PubMed ID: 22068806
    [Abstract] [Full Text] [Related]

  • 27. Dissociate expression of tuberous sclerosis complex 1 product hamartin in a skin and pulmonary lesion of a tuberous sclerosis complex.
    Wataya-Kaneda M, Katayama I.
    Hum Pathol; 2009 Mar; 40(3):430-4. PubMed ID: 18835623
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Tuberous sclerosis in childhood].
    Pires CF, Anunciação GM, De Sousa WL, Santos BM, Anunciação FA, Pires AF, Pires LF.
    Dermatol Online J; 2008 Sep 15; 14(9):14. PubMed ID: 19061596
    [Abstract] [Full Text] [Related]

  • 32. Neurofibromatosis type 1 and tuberous sclerosis: a case of double phakomatosis.
    Phillips CM, Rye B.
    J Am Acad Dermatol; 1994 Nov 15; 31(5 Pt 1):799-800. PubMed ID: 7929927
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Treatment of angiofibromas in tuberous sclerosis complex: the effect of topical rapamycin and concomitant laser therapy.
    Park J, Yun SK, Cho YS, Song KH, Kim HU.
    Dermatology; 2014 Nov 15; 228(1):37-41. PubMed ID: 24401865
    [Abstract] [Full Text] [Related]

  • 36. Tuberous sclerosis: a novel approach to diagnosis.
    Jahagirdar PB, Eeraveni R, Ponnuraj S, Kamarthi N.
    J Indian Soc Pedod Prev Dent; 2011 Dec 15; 29(6 Suppl 2):S52-5. PubMed ID: 22169838
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Topical rapamycin solution to treat multiple facial angiofibromas in a patient with tuberous sclerosis].
    Valerón-Almazán P, Vitiello M, Abuchar A, Kerdel FA.
    Actas Dermosifiliogr; 2012 Mar 15; 103(2):165-6. PubMed ID: 21861956
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.